NCT05037279 2026-03-20
EVER
Verity Pharmaceuticals Inc.
Phase 3 Recruiting
Clinical Trials
12 trialsNCT04165317 2026-01-22
CREST
Pfizer
Phase 3 Active not recruiting
NCT03799835 2024-12-11
ALBAN
UNICANCER
Phase 3 Active not recruiting
NCT04806178 2024-12-09
IMMUNOBCG
University of Campinas, Brazil
Phase 3 Completed
NCT00352079 2023-08-04
BCG With or Without Gefitinib in Treating Patients With High-Risk Bladder Cancer
Canadian Cancer Trials Group
Phase 3 Terminated
NCT02948543 2023-06-18
BCG+MM
University of Sydney
Phase 3 Unknown
NCT03664869 2021-04-01
FB10
Turku University Hospital
Phase 3 Unknown
NCT00974818 2015-11-20
Mitomycin C Versus Bacillus Calmette-Guerin in the Intravesical Treatment of Non-Muscle-Invasive Bladder Cancer Patients
Memorial Sloan Kettering Cancer Center
Phase 3 Terminated
NCT01284205 2014-08-29
First Line Comparative Study of EN3348 (MCC) vs BCG in NMIBC
Bioniche Life Sciences Inc.
Phase 3 Withdrawn
NCT00002490 2013-12-18
Radiation Therapy, Chemotherapy, or Observation in Treating Patients With Bladder Cancer
National Cancer Institute (NCI)
Phase 3 Completed
NCT00002990 2013-06-12
Surgery and BCG in Treating Patients With Bladder Cancer
European Organisation for Research and Treatment of Cancer - EORTC
Phase 3 Completed
NCT01442519 2011-09-28
BCG/EMDA-MMC
University of Rome Tor Vergata
Phase 3 Completed